Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b0c198757da18cf77dfbdcef00abb70 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 |
filingDate |
2003-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f441186f7baf4a5b171f064ee199d2b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37febfdc960de270d6b09c187770310f |
publicationDate |
2004-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2505898-A1 |
titleOfInvention |
Intrabodies against the oncogenic form of ras |
abstract |
The present invention relates to antibodies that function within an intracellular environment. In particular the present invention relates to a particular antibodies which the inventors have shown to bind to the oncogenic form of RAS. Uses of such an antibody are also described. |
priorityDate |
2002-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |